The presented invention comprises a theragnostic system that includes a carrier nanoparticle, a therapeutic agent of choice, an anti-FOLH1 monoclonal […]
Tag: #chemotherapy
RNA signature for the assessment of neoadjuvant chemotherapy response in triple-negative breast cancer
The present invention provides an in vitro method for the prediction of response to neoadjuvant chemotherapy (NAC), or for selecting […]